Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy.
about
Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease.Comparative study of two mechlorethamine, vincristine, procarbazine, and prednisone derived chemotherapeutic protocols for the management of pediatric Hodgkin lymphoma (HL): single-center 5-year experience.Relapsed Hodgkin lymphoma: management strategiesHistopathological pattern of lymphomas and clinical presentation and outcomes of diffuse large B cell lymphoma: A multicenter registry based study from India.Comparison of Ifosfamide, Carboplatin and Etoposide versus Etoposide, Steroid, and Cytarabine Cisplatin as Salvage Chemotherapy in Patients with Refractory or Relapsed Hodgkin's lymphoma.New strategies in Hodgkin lymphoma: better risk profiling and novel treatments.Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of Experience.Treatment of primary orbital lymphomas.Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma.
P2860
Q34545371-4E9FC20A-5E4E-4C0D-BD7C-E162A2BF5811Q34617599-4A787AB1-5216-4184-90EC-D8660E46CC7AQ37008427-E9800A56-5CD8-4A61-9D51-8A1B5085AFF5Q37599253-11FA35D9-4F9E-4399-BEC2-0E37C2104821Q37713596-5F851B89-2947-4EFE-BEE0-4FF000700BA0Q38085250-F5871403-FB9B-4879-9812-A475986657FBQ39195424-1564D2B1-4C6E-417D-ADB7-EB9FCB38F840Q42457181-37F94508-B8B4-46B0-BB31-0875005BE340Q53137051-785098FD-D842-4F1A-8256-654EA142C9AF
P2860
Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy.
@en
Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy.
@nl
type
label
Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy.
@en
Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy.
@nl
prefLabel
Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy.
@en
Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy.
@nl
P1476
Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy.
@en
P2093
Craig Moskowitz
P2888
P356
10.1007/S00280-002-0446-2
P478
49 Suppl 1
P577
2002-04-12T00:00:00Z